AC
ABBV icon

ASB Consultores’s AbbVie ABBV Stock Holding History

ASB Consultores’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,518
Closed -$467K – 32
2025
Q2 		$467K Sell
2,518
-300
-11% -$55.8K 0.31% 59
2025
Q1 		$590K Sell
2,818
-1,959
-41% -$381K 0.38% 37
2024
Q4 		$849K Buy
4,777
+544
+13% +$100K 0.35% 46
2024
Q3 		$836K Hold
4,233
– – 0.33% 49
2024
Q2 		$726K Sell
4,233
-1,032
-20% -$171K 0.26% 45
2024
Q1 		$959K Buy
5,265
+3,778
+254% +$651K 0.25% 58
2023
Q4 		$230K Sell
1,487
-1,232
-45% -$180K 0.08% 94
2023
Q3 		$405K Sell
2,719
-255
-9% -$37.4K 0.16% 64
2023
Q2 		$401K Sell
2,974
-289
-9% -$42.4K 0.19% 103
2023
Q1 		$520K Sell
3,263
-340
-9% -$52K 0.21% 66
2022
Q4 		$582K Sell
3,603
-441
-11% -$67.6K 0.24% 53
2022
Q3 		$543K Buy
4,044
+172
+4% +$24.7K 0.26% 50
2022
Q2 		$593K Buy
3,872
+486
+14% +$74.3K 0.26% 40
2022
Q1 		$549K Buy
3,386
+1,365
+68% +$198K 0.23% 71
2021
Q4 		$274K Buy
+2,021
New +$239K 0.14% 167

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ASB Consultores's ABBV Position: Q3 2025 in Review

ASB Consultores sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 2,518 shares — an estimated $467K sold.

ASB Consultores first reported a position in ABBV in Q4 2021 and held it in 15 quarters. The position peaked at $959K in Q1 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • ASB Consultores reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • ASB Consultores sold 2,518 AbbVie shares in Q3 2025, an estimated $467K.
  • ASB Consultores first reported a position in AbbVie in Q4 2021 and held it in 15 quarters.
  • ASB Consultores's AbbVie position peaked at $959K in Q1 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on ASB Consultores's 13F filing for Q3 2025, filed 4 Nov 2025.